Related Experiment Videos
Evaluation of interleukin 13 polymorphisms in systemic sclerosis.
Brigitte Granel1, Christophe Chevillard, Yannick Allanore
1Laboratoire d'Immunologie et de Génétique des Maladies Parasitaires, UMR 399 INSERM, Université de la Méditerranée, Faculté de Médecine, 13005, Marseille, France. brigitte.granel@medecine.univ-mrs.fr
Immunogenetics
|July 13, 2006
Summary
Genetic variations in the Interleukin-13 (IL-13) gene are linked to systemic sclerosis (SSc), a fibrotic disease. Specific IL-13 gene polymorphisms were more prevalent in SSc patients, suggesting a role in disease development.
Area of Science:
- Genetics
- Immunology
- Rheumatology
Background:
- Systemic sclerosis (SSc) is a complex multisystem disorder characterized by fibrosis and vascular damage.
- Interleukin-13 (IL-13), a cytokine implicated in fibrosis, is a potential factor in SSc pathogenesis.
Purpose of the Study:
- To investigate the association between IL-13 gene polymorphisms and systemic sclerosis.
- To explore the role of IL-13 in the fibrotic processes characteristic of SSc.
Main Methods:
- Analysis of four IL13 gene polymorphisms (rs1800925, rs20541, rs847, rs2243204) in 107 Caucasian SSc patients and 170 controls.
- Comparison of allele and genotype frequencies between patient subsets (diffuse vs. limited cutaneous SSc) and controls.
Main Results:
- An association was found between IL13 polymorphisms rs1800925 and rs2243204 and SSc in the total patient cohort and diffuse cutaneous subset.
- The IL13 rs2243204T allele showed increased frequency in SSc patients (OR=2.3) and particularly in the diffuse cutaneous form (OR=2.95) compared to controls.
Conclusions:
- Polymorphisms in the IL-13 gene are associated with systemic sclerosis and its fibrotic manifestations.
- Further research with larger populations and functional studies is warranted to validate these findings and elucidate the precise role of IL-13 in SSc.